Thai agency approves Pfizer vaccine for use in children age 5-11 | Inquirer News

Thai agency approves Pfizer vaccine for use in children age 5-11

/ 04:35 PM December 20, 2021

Thai agency approves Pfizer vaccine for use in children age 5-11

FILE PHOTO: Vials of the Pfizer-BioNTech vaccine against the coronavirus disease (COVID-19) are seen at a convention hall in the outskirts of Bangkok, Thailand, October 15, 2021. REUTERS/Athit Perawongmetha

BANGKOK Thailand’s Food and Drug Administration said Monday it has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children between the age of five and 11.

The Comirnaty vaccine, which is the first to be approved in Thailand for the age group, will be given in two 10 microgram doses, 21 days apart, the drug regulator said in a statement.

Article continues after this advertisement

RELATED STORY

Bahrain approves Pfizer COVID-19 vaccine for children age 5-11
FDA expects application for Pfizer vaccine use for kids 5 to 11 within the month

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Children, Comirnaty, COVID-19, Pfizer, Thailand, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.